Analyst firms · Citizens JMP · ALLO
Citizens JMP ALLO price target and rating history
Allogene Therapeutics Inc. (ALLO) · Health Care
Citizens JMP rates Allogene Therapeutics Inc. (ALLO) Mkt Outperform with a $5 price target, as of its latest action on Jan 9, 2026. It has published 5 rating actions on ALLO since October 2021, including 2 upgrades and 2 downgrades.
- Current rating
- Mkt Outperform
- Price target
- $5
- Median target, all firms
- Too few
- Actions on ALLO
- 5
Citizens JMP price target on ALLO
Every Citizens JMP rating on ALLO
- Jan 9, 2026
- May 14, 2025
- Mar 14, 2025
- Jan 5, 2024
- Oct 12, 2021
How other firms rate ALLO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Buy | $6 | Apr 10, 2026 |
| Citizens JMP | Mkt Outperform | $5 | Jan 9, 2026 |
Questions about Citizens JMP and ALLO
- What is Citizens JMP's price target for ALLO?
- Citizens JMP's latest stated price target for Allogene Therapeutics Inc. (ALLO) is $5, from its action on Jan 9, 2026.
- What is Citizens JMP's rating on ALLO?
- Citizens JMP rates ALLO Mkt Outperform, a bullish rating, as of Jan 9, 2026.
- When did Citizens JMP last change its view on ALLO?
- On Jan 9, 2026, Citizens JMP upgrades to Mkt Outperform from Mkt Perform, price target $5.
More ALLO rating histories
All Citizens JMP ratingsALLO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.